BioCentury | Jan 6, 2014
Company News

Melmed Holdings, Uluru sales and marketing update

...On Dec. 18, 2013, Uluru and Altrazeal AG (formerly Altrazeal Trading Ltd.) added rights in India...
...India to an expanded 2012 deal granting Altrazeal AG exclusive rights to commercialize antimicrobial dressing Altrazeal...
...New Zealand, Africa, the Middle East, Latin America and the Commonwealth of Independent States (CIS). Altrazeal...
BioCentury | Sep 23, 2013
Company News

Melmed Holdings, Uluru sales and marketing update

...Uluru and Altrazeal AG, an entity of Melmed, added rights in Latin America, the Commonwealth of...
...to a 2012 deal granting Altrazeal AG (formerly Altrazeal Trading Ltd.) exclusive rights to commercialize Altrazeal...
...dressing incorporating the company's Nanoflex nanoparticle aggregate technology in the U.S. for wound management, and Altrazeal...
BioCentury | Oct 1, 2012
Company News

Melmed Holdings, Uluru deal

...January, Uluru finalized a deal granting Melmed's Altrazeal Trading Ltd. subsidiary exclusive rights to commercialize Altrazeal...
BioCentury | Oct 1, 2012
Company News

Melmed Holdings, Uluru sales and marketing update

...Uluru said Melmed's Altrazeal Trading Ltd. subsidiary will launch Altrazeal in Austria this month. Uluru expects...
...launch in additional EU markets early next year. Melmed's subsidiary has exclusive rights to commercialize Altrazeal...
BioCentury | Jan 23, 2012
Company News

Melmed Holdings, Uluru sales and marketing update

...Uluru finalized a deal granting Melmed's Altrazeal Trading Ltd. subsidiary exclusive rights to commercialize Altrazeal in...
...Uluru will receive $250,000 in licensing fees and is eligible for royalties. Uluru will supply Altrazeal...
...under the deal. The subsidiary will receive $2 million from an investor group to launch Altrazeal...
BioCentury | Dec 19, 2011
Company News

Uluru, Melmed Holdings sales and marketing update

...to an October letter of intent granting an undisclosed Melmed subsidiary exclusive rights to commercialize Altrazeal...
BioCentury | Oct 24, 2011
Company News

Uluru, Melmed Holdings AG sales and marketing update

...Uluru signed a letter of intent to grant a Melmed subsidiary exclusive rights to commercialize Altrazeal...
...which Uluru said had a combined value of about $2.5 million. Uluru, which will supply Altrazeal...
BioCentury | Mar 21, 2011
Clinical News

Altrazeal regulatory update

...Uluru submitted an abbreviated 510(k) application to FDA to expand Altrazeal's label to include the management...
...under a 2010 deal (see BioCentury, July 5, 2010). Uluru Inc. (NYSE-A:ULU), Addison, Texas Product: Altrazeal...
BioCentury | Jul 5, 2010
Company News

Jiangxi Aiqilin Pharmaceuticals, Uluru deal

...Uluru granted Jiangxi rights to commercialize Altrazeal in China, Hong Kong, Macau and Taiwan. Uluru already...
...incorporating the company's Nanoflex nanoparticle aggregate technology in the U.S. for wound management. Uluru said Altrazeal...
...payment and is eligible for milestones and royalties. The license also includes Altrazeal Silver and Altrazeal...
BioCentury | Sep 28, 2009
Clinical News

Altrazeal: Post-marketing study data

...that Altrazeal led to significantly lower pain scores vs. a marketed silver-containing carboxymethylcellulose dressing (p<0.0001). Altrazeal...
...at the Symposium on Advanced Wound Care in Washington. Uluru Inc. (NYSE-A:ULU), Addison, Texas Product: Altrazeal...
Items per page:
1 - 10 of 13